Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
Mar Drugs ; 13(4): 2287-305, 2015 Apr 14.
Article in English | MEDLINE | ID: mdl-25874924

ABSTRACT

This study was designed to investigate the antimicrobial activity of two synthetic antimicrobial peptides from an aquatic organism, tilapia piscidin 3 (TP3) and tilapia piscidin 4 (TP4), in vitro and in a murine sepsis model, as compared with ampicillin, tigecycline, and imipenem. Mice were infected with (NDM-1)-producing K. pneumonia and multi-drug resistant Acinetobacter baumannii, and subsequently treated with TP3, TP4, or antibiotics for different periods of time (up to 168 h). Mouse survival and bacterial colony forming units (CFU) in various organs were measured after each treatment. Toxicity was determined based on observation of behavior and measurement of biochemical parameters. TP3 and TP4 exhibited strong activity against K. pneumonia and A. baumannii in vitro. Administration of TP3 (150 µg/mouse) or TP4 (50 µg/mouse) 30 min after infection with K. pneumonia or A. baumannii significantly increased survival in mice. TP4 was more effective than tigecycline at reducing CFU counts in several organs. TP3 and TP4 were shown to be non-toxic, and did not affect mouse behavior. TP3 and TP4 are able at potentiate anti-Acinetobacter baumannii or anti-Klebsiella pneumonia drug activity, reduce bacterial load, and prevent drug resistance, indicating their potential for use in combating multidrug-resistant bacteria.


Subject(s)
Acinetobacter Infections/drug therapy , Acinetobacter baumannii/drug effects , Anti-Bacterial Agents/therapeutic use , Antimicrobial Cationic Peptides/therapeutic use , Drug Resistance, Bacterial , Klebsiella Infections/drug therapy , Klebsiella pneumoniae/drug effects , Acinetobacter Infections/microbiology , Animals , Anti-Bacterial Agents/adverse effects , Anti-Bacterial Agents/pharmacology , Antimicrobial Cationic Peptides/adverse effects , Antimicrobial Cationic Peptides/genetics , Antimicrobial Cationic Peptides/pharmacology , Bacterial Proteins/biosynthesis , Behavior, Animal/drug effects , Carbapenems/pharmacology , Carbapenems/therapeutic use , Drug Resistance, Multiple, Bacterial , Fish Proteins/adverse effects , Fish Proteins/genetics , Fish Proteins/pharmacology , Fish Proteins/therapeutic use , Klebsiella Infections/microbiology , Klebsiella pneumoniae/metabolism , Male , Mice, Inbred C57BL , Microbial Sensitivity Tests , Protein Isoforms/adverse effects , Protein Isoforms/genetics , Protein Isoforms/pharmacology , Protein Isoforms/therapeutic use , Recombinant Proteins/adverse effects , Recombinant Proteins/pharmacology , Recombinant Proteins/therapeutic use , Sepsis/drug therapy , Sepsis/microbiology , Survival Analysis , Tilapia , beta-Lactamases/biosynthesis
2.
Antimicrob Agents Chemother ; 58(8): 4264-74, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24820078

ABSTRACT

Antimicrobial peptides (AMPs) are garnering attention as possible alternatives to antibiotics. Here, we describe the antimicrobial properties of epinecidin-1 against a multidrug-resistant clinical isolate of P. aeruginosa (P. aeruginosa R) and a P. aeruginosa strain from ATCC (P. aeruginosa ATCC 19660) in vivo. The MICs of epinecidin-1 against P. aeruginosa R and P. aeruginosa ATCC 19660 were determined and compared with those of imipenem. Epinecidin-1 was found to be highly effective at combating peritonitis infection caused by P. aeruginosa R or P. aeruginosa ATCC 19660 in mouse models, without inducing adverse behavioral effects or liver or kidney toxicity. Taken together, our results indicate that epinecidin-1 enhances the rate of survival of mice infected with the bacterial pathogen P. aeruginosa through both antimicrobial and immunomodulatory effects.


Subject(s)
Antimicrobial Cationic Peptides/pharmacology , Fish Proteins/pharmacology , Immunologic Factors/pharmacology , Pseudomonas Infections/drug therapy , Pseudomonas aeruginosa/pathogenicity , Sepsis/drug therapy , Amino Acid Sequence , Animals , Anti-Bacterial Agents/pharmacology , Antimicrobial Cationic Peptides/chemical synthesis , Behavior, Animal/drug effects , Disease Models, Animal , Drug Resistance, Multiple, Bacterial , Fish Proteins/chemical synthesis , Humans , Imipenem/pharmacology , Immunologic Factors/chemical synthesis , Male , Mice , Mice, Inbred C57BL , Microbial Sensitivity Tests , Molecular Sequence Data , Pseudomonas Infections/immunology , Pseudomonas Infections/microbiology , Pseudomonas Infections/mortality , Pseudomonas aeruginosa/drug effects , Pseudomonas aeruginosa/growth & development , Sepsis/immunology , Sepsis/microbiology , Sepsis/mortality , Survival Analysis , Toxicity Tests, Acute
3.
Br J Pharmacol ; 177(6): 1409-1423, 2020 03.
Article in English | MEDLINE | ID: mdl-31368509

ABSTRACT

Traditional chemotherapy is being considered due to hindrances caused by systemic toxicity. Currently, the administration of multiple chemotherapeutic drugs with different biochemical/molecular targets, known as combination chemotherapy, has attained numerous benefits like efficacy enhancement and amelioration of adverse effects that has been broadly applied to various cancer types. Additionally, seeking natural-based alternatives with less toxicity has become more important. Experimental evidence suggests that herbal extracts such as Solanum nigrum and Claviceps purpurea and isolated herbal compounds (e.g., curcumin, resveratrol, and matairesinol) combined with antitumoral drugs have the potential to attenuate resistance against cancer therapy and to exert chemoprotective actions. Plant products are not free of risks: Herb adverse effects, including herb-drug interactions, should be carefully considered. LINKED ARTICLES: This article is part of a themed section on The Pharmacology of Nutraceuticals. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v177.6/issuetoc.


Subject(s)
Curcumin , Neoplasms , Dietary Supplements , Humans , Neoplasms/drug therapy
4.
Ther Adv Chronic Dis ; 10: 2040622319875305, 2019.
Article in English | MEDLINE | ID: mdl-31555430

ABSTRACT

Dipeptidyl peptidase IV (DPP-4), an incretin glucagon-like peptide-1 (GLP-1) degrading enzyme, contains two forms and it can exert various physiological functions particular in controlling blood glucose through the action of GLP-1. In diabetic use, the DPP-4 inhibitor can block the DDP-4 to attenuate GLP-1 degradation and prolong GLP-1 its action and sensitize insulin activity for the purpose of lowering blood glucose. Nonetheless the adverse effects of DPP-4 inhibitors severely hinder their clinical applications, and notably there is a clinical demand for novel DPP-4 inhibitors from various sources including chemical synthesis, herbs, and plants with fewer side effects. In this review, we highlight various strategies, namely computational biology (in silico), in vitro enzymatic and cell assays, and in vivo animal tests, for seeking natural DPP-4 inhibitors from botanic sources including herbs and plants. The pros and cons of all approaches for new inhibitor candidates or hits will be under discussion.

5.
DNA Cell Biol ; 26(11): 781-90, 2007 Nov.
Article in English | MEDLINE | ID: mdl-17999625

ABSTRACT

Mitogen-activated protein kinase (MAPK) plays a pivotal role in intracellular actions in response to a variety of extracellular stimuli. Real-time reverse-transcription polymerase chain reaction analysis of MAPK3 tissue distribution in zebrafish showed significant differences in the fin and liver compared with muscle. A 1.2-kilobase (kb) pair and a 2.3-kb fragment of the 5'-flanking region displayed minimal promoter activity in the zebrafish liver (ZFL) and HeLa cell lines after treatment with insulin-like growth factors (IGF-I and IGF-II). Targeted knockdown of the MAPK3 gene by two antisense morpholino oligonucleotides revealed that although the zebrafish MAPK3 MO 1-targeted sequence was located at 5' untranslated region and the zebrafish MAPK3 MO 2-targeted sequence was located in the mature peptide region, similar results were shown in zebrafish for disruption of notochord development, with the whole body exhibiting distortion. From a comparative point of view, this study of the MAPK3 gene in zebrafish might not correlate well with previously published studies on mice. These molecular results suggest that MAPK3 plays an important role in whole-body development and is required for general embryonic development. Finally, MAPK3 may play important roles in fish cell growth.


Subject(s)
Gene Expression Regulation, Developmental , Mitogen-Activated Protein Kinase 3/genetics , Promoter Regions, Genetic , Zebrafish/embryology , Zebrafish/genetics , Animals , Base Sequence , Embryonic Development , Molecular Sequence Data , Oligonucleotides, Antisense/pharmacology , Organ Specificity , Reverse Transcriptase Polymerase Chain Reaction , Somatomedins/pharmacology , Tissue Distribution , Zebrafish Proteins/pharmacology , Zebrafish Proteins/physiology
6.
Int Immunopharmacol ; 7(5): 687-700, 2007 May.
Article in English | MEDLINE | ID: mdl-17386416

ABSTRACT

We investigated the efficacy of amino acids 55-76 of the synthetic shrimp anti-lipopolysaccharide factor peptide (SALF(55-76) cyclic peptide), the C-terminal part of the shrimp anti-lipopolysaccharide factor. This study was conducted to elucidate the effects of the antiseptic action of this peptide. The SALF(55-76) cyclic peptide was tested against bacterial clinical isolates and showed broad-spectrum antimicrobial activity. Transmission electron microscopic (TEM) examination of SALF(55-76) cyclic peptide-treated Pseudomonas aeruginosa showed that severe swelling preceded cell death and breakage of the outer membrane; the intracellular inclusion was found to have effluxed extracellularly. When mice were treated with the SALF(55-76) cyclic peptide before bacterial challenge with P. aeruginosa, the peptide highly protected mice against death by sepsis. The P. aeruginosa recovered from SALF(55-76) cyclic peptide-treated mice after 4 h exhibited reduced bacterial growth similar to that recovered from vancomycin-treated mice. In addition, the syntheses of inflammatory cytokines, such as interleukin (IL)-2, IL-4, IL-10, IL-12, IL-13, interferon-gamma, and tumor necrosis factor [TNF]-alpha, were significantly upregulated 4 h after SALF(55-76) cyclic peptide treatment except for IL-4 in the liver. The expressions of Toll-like receptor 4 (Tlr4), Irf3, myd88, and Tram, were considerably elevated, but only Tlr4 existed in the spleen 4 h after SALF(55-76) cyclic peptide treatment. The prophylactic administration of SALF(55-76) cyclic peptide was begun the TNF-alpha response in comparison to untreated mice by an ELISA analysis. Due to its multifunctional properties, the SALF(55-76) cyclic peptide may become an important prophylaxis against and therapy for bacterial infectious diseases, as well as for septic shock.


Subject(s)
Anti-Infective Agents/pharmacology , Penaeidae/chemistry , Peptide Fragments/pharmacology , Pseudomonas Infections/drug therapy , Pseudomonas aeruginosa , Sepsis/drug therapy , Amino Acid Sequence , Animals , Arthropod Proteins , Bacteria/drug effects , Cell Line, Tumor , Cell Survival , Cytokines/biosynthesis , Drug Screening Assays, Antitumor , Humans , Intestines/microbiology , Lipopolysaccharides/antagonists & inhibitors , Mice , Mice, Inbred BALB C , Microbial Sensitivity Tests , Microscopy, Electron, Transmission , Models, Molecular , Molecular Sequence Data , Pseudomonas Infections/microbiology , Pseudomonas Infections/mortality , Pseudomonas aeruginosa/drug effects , RNA, Messenger/biosynthesis , Reverse Transcriptase Polymerase Chain Reaction , Sepsis/microbiology , Sepsis/mortality
7.
DNA Cell Biol ; 24(10): 641-50, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16225395

ABSTRACT

Interferon plays important roles in confronting viral infections as the first line of defense. For the purpose of understanding the molecular mechanism which controls transcription of the interferon gene, we cloned and sequenced the interferon promoter region of the zebrafish interferon gene and characterized its activity using firefly luciferase transient transfection expression assays. Different fragments of the zebrafish interferon 5'-flanking region were transfected into ZFL cells. In these cell lines, maximum promoter activity was located in 2.2 kb of the zebrafish interferon 5' flanking region of the ZFL cell line. In this study, we investigated whether the viral replicative intermediate double-stranded RNA (herein we used synthetic polyinosinic-polycytidylic acid [poly(I):poly(C)] modifies the effects of interferon on gene expression. For this purpose, all zebrafish interferon promoter fragments were treated with either 1, 10, or 100 microg/ml poly(I):poly(C). The results showed that after treatment with 10 microg/ml poly(I):poly(C), high promoter activity was observed in the -2.2-kb interferon promoter fragment. Several putative transcription factors were shown in the promoter region, including IRF-1, C/EBP, NFkappaB, and GATA-1. Further study of the in vivo expression of the interferon promoter during development was carried out in transgenic zebrafish expressing an interferon promoter-driven green fluorescent protein (GFP) encoding the GFP cDNA transgene. Morphological studies of transgenic zebrafish indicated that the interferon promoter-driven GFP transcripts appeared in the yolk, head, and lymphoid organs. These results indicate that the interferon promoter is active in a tissue-specific manner, and suggest that the interferon promoter plays an important role in virus resistance during teleost growth.


Subject(s)
Gene Expression Regulation, Developmental , Interferons/genetics , Promoter Regions, Genetic/genetics , Transcription Factors/metabolism , Zebrafish/genetics , Amino Acid Sequence , Animals , Animals, Genetically Modified , Base Sequence , Cells, Cultured , DNA, Complementary/genetics , Embryo, Nonmammalian/physiology , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Interferons/metabolism , Mice , Molecular Sequence Data , NIH 3T3 Cells , Poly C/genetics , Poly I/genetics , RNA, Double-Stranded/genetics , Transcription, Genetic , Zebrafish/embryology , Zebrafish/growth & development
8.
Mar Biotechnol (NY) ; 6(1): 1-7, 2004.
Article in English | MEDLINE | ID: mdl-14605935

ABSTRACT

The biological functions of insulin-like growth factor (IGF) I and II are modulated by a family of IGF-binding proteins (IGFBPs) in complex IGF-dependent and IGF-independent pathways. For further understanding of the actions of IGFs, some of these binding proteins have been cloned and characterized. We report the molecular cloning of IGFBP-3 cDNA for zebrafish. The tissue-specific and developmental stage-specific expression of IGFBP-3 and the hormonal regulation of its expression have also been determined by comparative reverse transcription polymerase chain reaction. Zebrafish IGFBP-3 cDNA contains an open reading frame of 879 bp, encoding a polypeptide of 293 amino acid residues. Results of this analysis revealed high levels of IGFBP-3 messenger RNA in ovary and fin tissue. Expression of IGFBP-3 mRNA was throughout the entire embryonic development, with the highest level of expression observed at 36 hours after the onset of development. Elevated levels of expression of IGFBP-3 were observed 24 hours after injection with IGF-I and 48 hours with IGF-II or insulin. These results suggest that the expression of IGFBP3 gene might be modulated by IGF-I, IGF-II, and insulin.


Subject(s)
Gene Expression Regulation, Developmental/physiology , Insulin-Like Growth Factor Binding Protein 3/genetics , Zebrafish/embryology , Zebrafish/genetics , Amino Acid Sequence , Animals , DNA Primers , DNA, Complementary/genetics , Female , Food Deprivation/physiology , Gene Expression Regulation, Developmental/drug effects , Insulin/pharmacology , Insulin-Like Growth Factor Binding Protein 3/metabolism , Molecular Sequence Data , Ovary/metabolism , RNA, Messenger/genetics , Reverse Transcriptase Polymerase Chain Reaction , Sequence Alignment , Sequence Analysis, DNA , Somatomedins/pharmacology
9.
Comp Biochem Physiol B Biochem Mol Biol ; 136(1): 117-30, 2003 Sep.
Article in English | MEDLINE | ID: mdl-12941645

ABSTRACT

High-density lipoprotein-binding protein (HBP) plays a pivotal role in the endocrine regulation of both lipids and cholesterol. This first study of the zebrafish (Danio rerio) HBP gene in a piscine provides information on the complex molecular events that regulates lipid and cholesterol functions in fish, and allows a comparison with starvation and hormonal regulation. One identical zebrafish HBP cDNA clone was obtained from a 24-h-old zebrafish cDNA library. Zebrafish HBP is composed of 1273 amino acids as residues. The 1273-aa of HBP has 87.8% and 87.0% similarities to human and chicken HBP, respectively. Real-time reverse transcription polymerase chain reaction (RT-PCR) analysis showed that HBP is highly expressed in the 36 h of the developmental stage after fertilization as compared to other stages. As to tissue-specific expression, the HBP is highly expressed in the fin, liver and ovary. In the starvation experiment, results show significant differences between the control group and the group after 3-week starvation. After injecting GH, IGF-I, IGF-II or insulin, no significant differences were shown between the control and the experimental groups. These results suggest that in vivo HBP expression is not regulated by the insulin family or by growth hormone, but other factors present during the starvation may down- or up-regulate the HBP. Although the exact function of the HBP is unknown, its high expression in the liver and ovary suggests a role for this molecule in the cumulative efficiency of fish intake of food or lipid transfer; these results can possibly be applied to aquaculture in the near future.


Subject(s)
Carrier Proteins/genetics , Cloning, Molecular , DNA-Binding Proteins , Zebrafish Proteins , Zebrafish/genetics , Animals , Base Sequence , Carrier Proteins/chemistry , Carrier Proteins/physiology , DNA, Complementary , Gene Expression Regulation, Developmental , Hormones/pharmacology , Insulin/pharmacology , Molecular Sequence Data , RNA, Messenger/analysis , Reverse Transcriptase Polymerase Chain Reaction , Starvation , Tissue Distribution
10.
J Pharm Pharmacol ; 66(1): 73-83, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24164544

ABSTRACT

OBJECTIVES: The aim of this research is to investigate whether the oxygen atom O(6) in the sydnone ring of 3-arylsydnone-4-carbaldehyde N(4)-phenylthiosemicarbazones (HArSYTSCs, 3a-d) is a good electron donor atom upon metal complexation. Furthermore, ligands 3a-d and the corresponding palladium complexes (Pd(ArSYTSC)Cl, 4a-d) would be expected to find their potent biological activities. METHODS: The desired palladium complexes 4a-d were first synthesized from thiosemicarbazones 3a-d. Then, the antiproliferative activity of ligands 3a-d and complexes 4a-d were tested against human hepatocellular carcinoma and human cervical epithelioid carcinoma (HeLa) cells by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl trazolium bromide (MTT) assay. KEY FINDINGS: According to X-ray analyses, ligands 3a-d are bonded to the Pd (II) center in an O, N, S-tridentate coordination mode through sydnone carbonyl oxygen O(6), azomethine nitrogen and the thiolate sulfur atom. The carbonyl oxygen of the sydnone ring is found to be a good electron donor site upon metal complexation. Moreover, MTT assay results reveal that the palladium complexes 4a-d have greater antiproliferative activity than 5-fluorouracil. In particular, the complexes exhibit obvious better activity than the corresponding ligands 3a-d against HeLa cell. CONCLUSIONS: The results indicate that the synthesized novel palladium complexes have greater antiproliferative activity than both 5-fluorouracil and the corresponding ligands against HeLa cell. Accordingly, the study of sydnonyl complexes bearing anticancer activities may support the development of coordination chemistry.


Subject(s)
Coordination Complexes/chemical synthesis , Coordination Complexes/pharmacology , Palladium/chemistry , Palladium/pharmacology , Thiosemicarbazones/chemistry , Cell Line, Tumor , Cell Proliferation/drug effects , HeLa Cells , Hep G2 Cells , Humans , Ligands
11.
Food Chem Toxicol ; 69: 150-62, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24751970

ABSTRACT

The direct modulation of Antrodia cinnamomea (AC) on the prominent role of liver fibrosis-hepatic stellate cells (HSCs) in situ remains unclear. Firstly, the administration of A. cinnamomea mycelial extract (ACME) could improve liver morphology and histological changes including collagen formation and GPT activity in the liver of thioacetamide (TAA)-injured rats. The morphology and fatty acid restore of TAA-induced HSCs (THSCs) returned to the non-chemical induced HSCs (NHSCs) type as measured by immunofluorescence and Oil Red O staining. PPARγ was upregulated associated with the lowering of α-SMA protein in NHSC-ACME. ACME inhibited the MMP-2 activity in NHSCs by gelatin Zymography. After LC-MS/MS, the cytoskeleton (tubulin, lamin A) and heat shock protein 8 in NHSC-ACME, and guanylate kinase, brain-specific kinase, SG-II and p55 proteins were downregulated in THSC-ACME. Whereas MHC class II, SMC6 protein, and phospholipase D were upregulated in NHSC-ACME. Furthermore, PKG-1 was downregulated in NHSC-ACME and upregulated in THSC-ACME. SG-II and p55 proteins were downregulated in NHSC-ACME and THSC-ACME by Western blotting. Taken together, the beneficial effect of A. cinnamomea on the induction of HSC cellular proteins is potentially applied as an alternative and complementary medicine for the prevention and amelioration of a liver injury.


Subject(s)
Antrodia/chemistry , Hepatic Stellate Cells/drug effects , Plant Extracts/pharmacology , Actins/metabolism , Animals , Biomarkers/metabolism , Cell Survival/drug effects , Fatty Acids/metabolism , Functional Food , Hepatic Stellate Cells/metabolism , Male , Matrix Metalloproteinase 2/metabolism , Matrix Metalloproteinase Inhibitors/pharmacology , PPAR gamma/metabolism , Rats, Sprague-Dawley , Thioacetamide/toxicity
12.
Chin Med ; 7(1): 24, 2012 Nov 07.
Article in English | MEDLINE | ID: mdl-23134744

ABSTRACT

BACKGROUND: Xiao-Yao-San (XYS) is a Chinese medicinal formula for treating anxiety and depression. This study aims to evaluate the use of a room-temperature super-extraction system (RTSES) to extract the major active components of XYS and enhance their psycho-pharmacological effects. METHODS: The neuroprotective roles of XYS/RTSES against reserpine-derived neurotoxicity were evaluated using a glial cell injury system (in vitro) and a depression-like C57BL/6 J mouse model (in vivo). The anxiolytic-behavioural effects were measured by the elevated plus-maze (EPM) test and the antidepressant effects were evaluated by the forced swimming test (FST) and tail suspension test (TST). Glucose tolerance and insulin resistance were assayed by ELISA. The expression of 5-HT1A receptors in the prefrontal cortex was examined by western blotting. RESULTS: XYS/RTSES (300 µg/mL) diminished reserpine-induced glial cell death more effectively than either XYS (300 µg/mL) or fluoxetine (30 µM) at 24 h (P = 0.0481 and P = 0.054, respectively). Oral administration of XYS/RTSES (500 mg/kg/day) for 4 consecutive weeks significantly elevated the ratios of entries (open arms/closed arms; P = 0.0177) and shuttle activity (P = 0.00149) on the EPM test, and reduced the immobility time by 90% on the TST (P = 0.00000538) and FST (P = 0.0000053839). XYS/RTSES also improved the regulation of blood glucose (P = 0.0305) and increased the insulin sensitivity (P = 0.0093). The Western blot results indicated that the activation of cerebral 5-HT1A receptors may be involved in the mechanisms of XYS/RTSES actions. CONCLUSION: The RTSES could provide a novel method for extracting effective anxiolytic- and antidepressant-like substances. XYS/RTSES improved the regulation of blood glucose and increased the insulin sensitivity in reserpine-induced anxiety and depression. Neuroprotection of glial cells and activation of cerebral 5-HT1A receptors were also involved.

13.
Peptides ; 31(5): 806-15, 2010 May.
Article in English | MEDLINE | ID: mdl-20138098

ABSTRACT

Antimicrobial peptides (AMPs) are effective against a wide range of microbes, but still no research results have reported their use in duck disease therapy. Riemerella anatipestifer (RA) is a Gram-negative bacterium which infects ducks and causes very significant economic losses. The minimum inhibitory concentrations (MICs) of epinecidin-1 for the tested RA strains ranged 6.25-50microg/ml, those of the SALF55-76 cyclic peptide ranged 12.5-25microg/ml, those of the SALF55-76 linear peptide ranged 6.25-25microg/ml, those of hepcidin TH1-5 ranged 25-400microg/ml, and those of hepcidin TH2-3 ranged 100-400microg/ml. The antimicrobial activities of these peptides were confirmed by transmission electron microscopy which showed that RA disruption of the outer membrane brought about cell death. In addition, pretreatment, co-treatment, and post-treatment with peptides were all effective in promoting a significant decrease in duck mortality and decreasing the number of infectious bacteria. A quantitative RT-PCR was performed to survey levels of gene expressions of Mn superoxide dismutase in the brain, lipoprotein lipase in the liver, and H5 histone in the spleen induced in response to bacterial infection and an injection of the AMPs in experiments with the duck, Cairina moschata. Our results indicated that the rescue of ducks by the peptides and the behavior of the peptides, which was like an enhancer in immunology, may involve regulation of the expressions of these genes. Collectively, these peptides reduced the mortality in ducks during bacterial challenge, suggesting that AMPs have the potential to serve as therapeutic drugs for use against bacterial infectious diseases in ducks.


Subject(s)
Antimicrobial Cationic Peptides/therapeutic use , Flavobacteriaceae/pathogenicity , Lipopolysaccharides/antagonists & inhibitors , Poultry Diseases/drug therapy , Sepsis/drug therapy , Animals , Antimicrobial Cationic Peptides/chemical synthesis , Antimicrobial Cationic Peptides/chemistry , Ducks , Flavobacteriaceae/ultrastructure , Flavobacteriaceae Infections/drug therapy , Flavobacteriaceae Infections/microbiology , Hepcidins , Liver/metabolism , Liver/microbiology , Microscopy, Electron, Transmission , Poultry Diseases/microbiology , Reverse Transcriptase Polymerase Chain Reaction , Sepsis/microbiology
14.
Peptides ; 31(6): 1019-25, 2010 Jun.
Article in English | MEDLINE | ID: mdl-20214941

ABSTRACT

The antitumor activity of the shrimp anti-lipopolysaccharide factor (SALF), an antimicrobial peptide, was not previously examined. In this study, a synthetic SALF was tested for antitumor activity using HeLa cells as the study model. We show that the SALF inhibited the proliferation of HeLa cells and reduced colony formation in a soft agar assay. An enhanced effect was observed when the SALF and cisplatin were used in combination, which caused significant inhibition of HeLa cells. Scanning electron microscopy (SEM) and transmission electron microscopy (TEM) showed that the SALF altered the membrane structure similar to what a lytic peptide does. A flow cytometric analysis, qRT-PCR, and Western blotting showed that the SALF induced apoptosis, activated caspases-6, -7, and -9, and downregulated Bcl-2 and nuclear factor (NF)-kappaB suggesting that the SALF induces apoptosis through the death receptor/NF-kappaB signaling pathway. An in vivo analysis revealed that the SALF displayed significant tumor suppressive activity in mice with tumor xenografts. Overall, these results indicated that the SALF possesses the potential to be a novel therapeutic agent for treating cervical cancer.


Subject(s)
Antineoplastic Agents/pharmacology , Cisplatin/therapeutic use , Peptide Fragments/pharmacology , Animals , Apoptosis/drug effects , Arthropod Proteins , Caspases/physiology , Cell Membrane/drug effects , Cell Proliferation/drug effects , HeLa Cells , Humans , Mice , Mice, Nude
15.
Int Heart J ; 50(2): 207-20, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19367031

ABSTRACT

Antrodia camphorata (AC) is a well-known traditional Chinese medicine that has been shown to inhibit proliferation and migration of cancer cells. We examined whether AC could inhibit rat aortic smooth muscle cell (RASMC) proliferation and migration and evaluated its effect on neointima formation in mouse carotid artery after injury. In Transwell migration assay and wound scratch assay, RASMCs were treated with AC or saline, and the number of migrated cells was counted or the distance was determined. Both assays showed that AC significantly inhibited platelet-derived growth factor (PDGF)-induced SMC migration. In 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) and 5-bromo-2' deoxyuridine (BrdU) proliferation assays, RASMCs were pretreated with AC or saline and stimulated with PDGF. Both assays showed that AC inhibited PDGF-induced SMC proliferation. The left common carotid arteries of C57BL/6 mice were ligated near the carotid bifurcation. The mice were given water or AC for 4 weeks. The severity of neointima formation was expressed as the neointima/media (N/M) ratio. The AC-treated mice had less neointima formation at 4 weeks after carotid ligation (N/M ratio, water versus 250 versus 1250 mg/kg AC; 1.33 +/- 0.87 versus 0.83 +/- 0.45 versus 0.63 +/- 0.32, P < 0.05).Our data indicate that AC is an effective inhibitor of PDGF-induced RASMC proliferation and migration. AC treatment reduced neointima formation in this mouse carotid ligation model.


Subject(s)
Antrodia/chemistry , Aorta , Carotid Artery Injuries/drug therapy , Muscle, Smooth, Vascular/drug effects , Myocytes, Smooth Muscle/drug effects , Neovascularization, Pathologic/prevention & control , Platelet-Derived Growth Factor/drug effects , Tunica Intima/drug effects , Algorithms , Animals , Cell Movement/drug effects , Cells, Cultured , Disease Models, Animal , Fruiting Bodies, Fungal/chemistry , In Vitro Techniques , Male , Medicine, Chinese Traditional , Mice , Mice, Inbred C57BL , Muscle, Smooth, Vascular/pathology , Neoplasms/drug therapy , Rats
SELECTION OF CITATIONS
SEARCH DETAIL